Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
72,119,556
-
Total 13F shares
-
15,453,557
-
Share change
-
+594,705
-
Total reported value
-
$72,167,000
-
Price per share
-
$4.67
-
Number of holders
-
18
-
Value change
-
+$2,681,635
-
Number of buys
-
8
-
Number of sells
-
9
Institutional Holders of IO Biotech, Inc. - Common (IOBT) as of Q2 2022
As of 30 Jun 2022,
IO Biotech, Inc. - Common (IOBT) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,453,557 shares.
The largest 10 holders included
Novo Holdings A/S, Vivo Capital, LLC, PFM Health Sciences, LP, Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Capital World Investors, Samsara BioCapital, LLC, Soleus Capital Management, L.P., BRIDGEWAY CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.